Siegel RL, Giaquinto AN ( 2024) Cancer statistics, 2024. CA: a cancer journal for clinicians 74:12–49. https://doi.org/10.3322/caac.21820
March B, Faulkner S (2020) Tumour innervation and neurosignalling in prostate cancer. Nat Reviews Urol 17:119–130. https://doi.org/10.1038/s41585-019-0274-3
Magnon C, Hall SJ, Lin J, Xue X, Gerber L, Freedland SJ et al (2013) Autonomic nerve development contributes to prostate cancer progression. Sci (New York NY) 341:1236361. https://doi.org/10.1126/science.1236361
Liebig C, Ayala G, Wilks JA, Berger DH, Albo D (2009) Perineural invasion in cancer: a review of the literature. Cancer 115:3379–3391. https://doi.org/10.1002/cncr.24396
Article CAS PubMed Google Scholar
Lubig S, Thiesler T, Müller S, Vorreuther R, Leipner N, Kristiansen G (2018) Quantitative perineural invasion is a prognostic marker in prostate cancer. Pathology 50:298–304. https://doi.org/10.1016/j.pathol.2017.09.013
Turner RM 2, Yecies TS, Yabes JG, Ristau BT, Woldemichael E, Davies BJ et al (2017) Biopsy perineural invasion in prostate cancer patients who are candidates for active surveillance by strict and expanded criteria. Urology 102:173–177. https://doi.org/10.1016/j.urology.2016.11.011
Moreira DM, Fleshner NE, Freedland SJ (2015) Baseline perineural invasion is associated with shorter time to progression in men with prostate cancer undergoing active surveillance: results from the REDEEM Study. J Urol 194:1258–1263. https://doi.org/10.1016/j.juro.2015.04.113
Loeb S, Epstein JI, Humphreys EB, Walsh PC (2010) Does perineural invasion on prostate biopsy predict adverse prostatectomy outcomes? BJU Int 105:1510–1513. https://doi.org/10.1111/j.1464-410X.2009.08845.x
Ciftci S, Yilmaz H, Ciftci E, Simsek E, Ustuner M, Yavuz U et al (2015) Perineural invasion in prostate biopsy specimens is associated with increased bone metastasis in prostate cancer. Prostate 75:1783–1789. https://doi.org/10.1002/pros.23067
Cohn JA, Dangle PP, Wang CE, Brendler CB, Novakovic KR, McGuire MS et al (2014) The prognostic significance of perineural invasion and race in men considering active surveillance. BJU Int 114:75–80. https://doi.org/10.1111/bju.12463
Liu H, Zhou H, Yan L, Ye T, Lu H, Sun X et al (2018) Prognostic significance of six clinicopathological features for biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis. Oncotarget 9:32238–32249. https://doi.org/10.18632/oncotarget.22459
Zhang LJ, Wu B, Zha ZL, Qu W, Zhao H, Yuan J et al (2018) Perineural invasion as an independent predictor of biochemical recurrence in prostate cancer following radical prostatectomy or radiotherapy: a systematic review and meta-analysis. BMC Urol 18:5. https://doi.org/10.1186/s12894-018-0319-6
Article PubMed PubMed Central Google Scholar
DeLancey JO, Wood DP Jr, He C, Montgomery JS, Weizer AZ, Miller DC et al (2013) Evidence of perineural invasion on prostate biopsy specimen and survival after radical prostatectomy. Urology 81:354–357. https://doi.org/10.1016/j.urology.2012.09.034
Peng LC, Narang AK, Gergis C, Radwan NA, Han P, Marciscano AE et al (2018) Effects of perineural invasion on biochemical recurrence and prostate cancer-specific survival in patients treated with definitive external beam radiotherapy. Urol Oncol 36:309e7-e3014. https://doi.org/10.1016/j.urolonc.2018.02.008
Sachpekidis C, Kopka K, Eder M, Hadaschik BA, Freitag MT, Pan L et al (2016) 68Ga-PSMA-11 dynamic PET/CT imaging in primary prostate ancer. Clin Nucl Med 41:e473–e479. https://doi.org/10.1097/rlu.0000000000001349
Koerber SA, Utzinger MT, Kratochwil C, Kesch C, Haefner MF, Katayama S et al (2017) (68)Ga-PSMA-11 PET/CT in newly diagnosed Carcinoma of the prostate: correlation of Intraprostatic PSMA Uptake with several clinical parameters. Journal of nuclear medicine: official publication. Soc Nuclear Med 58:1943–1948. https://doi.org/10.2967/jnumed.117.190314
Uprimny C, Kroiss AS, Decristoforo C, Fritz J, von Guggenberg E, Kendler D et al (2017) (68)Ga-PSMA-11 PET/CT in primary staging of prostate cancer: PSA and Gleason score predict the intensity of tracer accumulation in the primary tumour. Eur J Nucl Med Mol Imaging 44:941–949. https://doi.org/10.1007/s00259-017-3631-6
Article CAS PubMed Google Scholar
Perera M, Papa N, Christidis D, Wetherell D, Hofman MS, Murphy DG et al (2016) Sensitivity, specificity, and predictors of positive (68)Ga-Prostate-specific membrane antigen positron emission tomography in advanced prostate ancer: a systematic review and Meta-analysis. Eur Urol 70:926–937. https://doi.org/10.1016/j.eururo.2016.06.021
Ross JS, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, Gray K et al (2003) Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer. Clin cancer Res: Off J Am Assoc Cancer Res 9:6357–6362
Farolfi A, Calderoni L, Mattana F, Mei R, Telo S, Fanti S et al (2021) Current and emerging clinical applications of PSMA PET Diagnostic imaging for prostate Cancer. J Nucl Med: Off Publ Soc Nuclear Med 62:596–604. https://doi.org/10.2967/jnumed.120.257238
Weinreb JC, Barentsz JO, Choyke PL, Cornud F, Haider MA, Macura KJ et al (2016) PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. Eur Urol 69:16–40. https://doi.org/10.1016/j.eururo.2015.08.052
Eiber M, Herrmann K, Calais J, Hadaschik B, Giesel FL, Hartenbach M et al (2018) Prostate ancer molecular imaging standardized evaluation (PROMISE): proposed miTNM classification for the interpretation of PSMA-Ligand PET/CT. J Nucl Med: Off Publ Soc Nuclear Med 59:469–478. https://doi.org/10.2967/jnumed.117.198119
Epstein JI, Egevad L, Amin MB, Delahunt B, Srigley JR, Humphrey PA (2016) The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J surg pathol 40:244–252. https://doi.org/10.1097/pas.0000000000000530
Bründl J, Schneider S, Weber F, Zeman F, Wieland WF, Ganzer R (2014) Computerized quantification and planimetry of prostatic capsular nerves in relation to adjacent prostate cancer foci. Eur Urol 65:802–808. https://doi.org/10.1016/j.eururo.2013.04.043
Hanahan D, Monje M (2023) Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell 41:573–580. https://doi.org/10.1016/j.ccell.2023.02.012
Article CAS PubMed PubMed Central Google Scholar
Magnon C, Hondermarck H (2023) The neural addiction of cancer. Nat Rev Cancer 23:317–334. https://doi.org/10.1038/s41568-023-00556-8
留言 (0)